Literature DB >> 7572666

A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction.

M J de Boer1, B A van Hout, A L Liem, H Suryapranata, J C Hoorntje, F Zijlstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7572666     DOI： 10.1016/s0002-9149(99)80238-0

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  17 in total

Review 1.  The limited incorporation of economic analyses in clinical practice guidelines.

Authors:  Joel F Wallace; Scott R Weingarten; Chiun-Fang Chiou; James M Henning; Andriana A Hohlbauch; Margaret S Richards; Nicole S Herzog; Lior S Lewensztain; Joshua J Ofman
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

Review 2.  Treating myocardial infarction in the post-GUSTO era. A European perspective.

Authors:  M J de Boer; F Zijlstra
Journal:  Pharmacoeconomics       Date:  1997-10       Impact factor: 4.981

3.  Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction.

Authors:  H Suryapranata; J P Ottervanger; E Nibbering; A W van 't Hof; J C Hoorntje; M J de Boer; M J Al; F Zijlstra
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

4.  Can the published cost analysis data for delivery of an efficient primary angioplasty service be applied to the modern National Health Service?

Authors:  N Melikian; K Morgan; K J Beatt
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

5.  Angioplasty for the treatment of acute myocardial infarction.

Authors:  K J Beatt; F Fath-Ordoubadi
Journal:  Heart       Date:  1997-10       Impact factor: 5.994

Review 6.  Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.

Authors:  J C Gillis; K L Goa
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

7.  Costs and effectiveness of using coumarins before, during and after coronary angioplasty.

Authors:  Jurrien M ten Berg; Johannas C Kelder; Thys H W Plokker; Ben A van Hout
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-08-01

9.  Primary coronary intervention for ST-elevation myocardial infarction in Indonesia and the Netherlands: a comparison.

Authors:  Y B Juwana; J Wirianta; J P Ottervanger; J H E Dambrink; A W J van 't Hof; A T M Gosselink; J Hoorntje; M J de Boer; H Suryapranata
Journal:  Neth Heart J       Date:  2009-11       Impact factor: 2.380

10.  Long-term clopidogrel therapy in patients receiving percutaneous coronary intervention.

Authors:  Bart M S Heeg; Ron J G Peters; Marc Botteman; Ben A van Hout
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.